12-6349108-G-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001038.6(SCNN1A):c.1497+56C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 1,602,410 control chromosomes in the GnomAD database, including 40,417 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.20   (  3113   hom.,  cov: 31) 
 Exomes 𝑓:  0.22   (  37304   hom.  ) 
Consequence
 SCNN1A
NM_001038.6 intron
NM_001038.6 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.342  
Publications
16 publications found 
Genes affected
 SCNN1A  (HGNC:10599):  (sodium channel epithelial 1 subunit alpha) Nonvoltage-gated, amiloride-sensitive, sodium channels control fluid and electrolyte transport across epithelia in many organs. These channels are heteromeric complexes consisting of 3 subunits: alpha, beta, and gamma. This gene encodes the alpha subunit, and mutations in this gene have been associated with pseudohypoaldosteronism type 1 (PHA1), a rare salt wasting disease resulting from target organ unresponsiveness to mineralocorticoids. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2009] 
SCNN1A Gene-Disease associations (from GenCC):
- pseudohypoaldosteronism, type IB1, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Laboratory for Molecular Medicine, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- bronchiectasis with or without elevated sweat chloride 2Inheritance: Unknown, AD Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
- Brugada syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Liddle syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Liddle syndrome 3Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84). 
BP6
Variant 12-6349108-G-C is Benign according to our data. Variant chr12-6349108-G-C is described in ClinVar as Benign. ClinVar VariationId is 1271585.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.272  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SCNN1A | NM_001038.6 | c.1497+56C>G | intron_variant | Intron 10 of 12 | ENST00000228916.7 | NP_001029.1 | ||
| SCNN1A | NM_001159576.2 | c.1674+56C>G | intron_variant | Intron 9 of 11 | NP_001153048.1 | |||
| SCNN1A | NM_001159575.2 | c.1566+56C>G | intron_variant | Intron 10 of 12 | NP_001153047.1 | |||
| LOC107984500 | XR_007063191.1 | n.87+841G>C | intron_variant | Intron 1 of 3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.199  AC: 30179AN: 151914Hom.:  3109  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
30179
AN: 
151914
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.224  AC: 324898AN: 1450378Hom.:  37304  Cov.: 29 AF XY:  0.226  AC XY: 163077AN XY: 722360 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
324898
AN: 
1450378
Hom.: 
Cov.: 
29
 AF XY: 
AC XY: 
163077
AN XY: 
722360
show subpopulations 
African (AFR) 
 AF: 
AC: 
4816
AN: 
33262
American (AMR) 
 AF: 
AC: 
7548
AN: 
44710
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4889
AN: 
26062
East Asian (EAS) 
 AF: 
AC: 
5932
AN: 
39630
South Asian (SAS) 
 AF: 
AC: 
24403
AN: 
86006
European-Finnish (FIN) 
 AF: 
AC: 
12098
AN: 
53400
Middle Eastern (MID) 
 AF: 
AC: 
1077
AN: 
5448
European-Non Finnish (NFE) 
 AF: 
AC: 
251098
AN: 
1101878
Other (OTH) 
 AF: 
AC: 
13037
AN: 
59982
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 13991 
 27982 
 41972 
 55963 
 69954 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 8552 
 17104 
 25656 
 34208 
 42760 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.199  AC: 30193AN: 152032Hom.:  3113  Cov.: 31 AF XY:  0.201  AC XY: 14904AN XY: 74322 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
30193
AN: 
152032
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
14904
AN XY: 
74322
show subpopulations 
African (AFR) 
 AF: 
AC: 
6263
AN: 
41478
American (AMR) 
 AF: 
AC: 
2413
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
670
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
667
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
1373
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
2403
AN: 
10566
Middle Eastern (MID) 
 AF: 
AC: 
52
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
15617
AN: 
67918
Other (OTH) 
 AF: 
AC: 
392
AN: 
2116
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1243 
 2486 
 3728 
 4971 
 6214 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 336 
 672 
 1008 
 1344 
 1680 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
755
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Sep 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.